![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 05, 2018 10:35:30 AM
From Sree Koneru
Thank you for your e-mail. We are in the process of seeking guidance from the FDA on the appropriate time to submit the RecoveryRx 510(k), with respect to the Innovation Challenge. The Allay study is going strong and we expect a timely completion this year, however we do not have additional information on when the 510(k) will be filed. Any updates that we have regarding these two matters will be made publicly available via a press release.
![](http://investorshub.advfn.com/uimage/uploads/2018/5/23/oiwblactipatch_airplane.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2018/5/17/jktxdactipatch_bart.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2018/5/11/mqoilactipatch_catbanana.jpg)
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM